Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
COVID-19 vaccines
COVID-19 vaccines
Page 39 of 95
Magazine
Moderna’s COVID vaccine success made the stock a big pandemic winner. Will the run continue?
By
Rey Mashayekhi
December 2, 2021
Commentary
If we want the pandemic to end, CEOs need to do what governments won’t—including getting tougher and smarter about vaccines
By
Mark Dybul
and
Serhat Gümrükçü
December 1, 2021
Politics
Europe is hitting the unvaccinated with fines, lockdowns, and mandates. Could America be next?
By
Sophie Mellor
December 1, 2021
Health
Europe’s leaders turn to vaccine mandates as the winter COVID wave worsens, and Omicron looms
By
David Meyer
December 1, 2021
Health
Why COVID pills are likely to maintain efficacy against the Omicron COVID variant—even if vaccines don’t
By
Grady McGregor
December 1, 2021
Health
COVID infections are rising again as the Omicron variant emerges in nearly 20 countries
By
Erika Fry
and
Nicolas Rapp
November 30, 2021
Health
Moderna CEO expects a ‘material drop’ in COVID vaccine effectiveness from Omicron variant
By
Kylie Logan
November 30, 2021
Newsletters
Beware knee-jerk reactions to Omicron, as there is so much we don’t yet know about the new COVID-19 variant
By
David Meyer
November 30, 2021
Newsletters
Omicron fears rock the global markets—crude, crypto and stocks all tumble
By
Bernhard Warner
November 30, 2021
Health
Moderna’s CEO believes new COVID vaccines are likely needed to protect against the Omicron variant
By
Michelle Fay Cortez
and
Bloomberg
November 30, 2021
Health
Biden says Omicron demands that countries share vaccines as China donates 1 billion doses to Africa
By
Grady McGregor
November 30, 2021
Health
Biden says he’s not considering lockdowns in fight against Omicron COVID variant
By
Marco Quiroz-Gutierrez
November 29, 2021
Health
Biden administration to delay firing of unvaccinated federal workers until 2022
By
Josh Wingrove
and
Bloomberg
November 29, 2021
Commentary
The most important meeting yet for global pandemic response—and drugmakers
By
Nicole Hassoun
and
Kaushik Basu
November 29, 2021
Health
Holiday travel plans are in limbo as a growing list of countries introduce bans designed to stop the Omicron variant
By
Katherine Dunn
November 29, 2021
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House post
By
Eleanor Pringle
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By
Emma Burleigh
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the board
By
Jim Edwards